Colon and rectal cancer after renal transplantation

References

• Hawk ET, Umar A, Richmond E, Viner JL. Prevention and therapy of colorectal cancer. Med. Clin. North Am.89(1), 85–110 (2005).
   Google Scholar
• Lynch HT, De la Chapelle A. Hereditary colorectal cancer. N. Engl. J. Med.348, 919–932 (2003).
   PubMed Web of Science ®Google Scholar
• Koushik A, Hunter DJ, Spiegelman D et al. Fruits, vegetables, and colon cancer risk in a pooled analysis of 14 cohort studies. J. Natl Cancer Inst.99(19), 1471–1483 (2007).
   PubMed Web of Science ®Google Scholar
• Chan AT, Ogino S, Fuchs CS. Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N. Engl. J. Med.356(21), 2131–2142 (2007).
   PubMed Web of Science ®Google Scholar
• Colangelo LA, Gapstur SM, Gann PH, Dyer AR. Cigarette smoking and colorectal carcinoma mortality in a cohort with long-term follow-up. Cancer100(2), 223–224 (2004).
   Google Scholar
• Chao A, Thun MJ, Jacobs EJ, Henley SJ, Rodriguez C, Calle EE. Cigarette smoking and colorectal cancer mortality in the cancer prevention study II. J. Natl Cancer Inst.92(23), 1888–1896 (2000).
   PubMedGoogle Scholar
• Wu WK, Wong HP, Luo SW et al. 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone from cigarette smoke stimulates colon cancer growth via b-adrenoceptors. Cancer Res.65(12), 5272 (2005).
   PubMed Web of Science ®Google Scholar
• Villeneuve PJ, Schaubel DE, Fenton SS et al. Cancer incidence among Canadian kidney transplant recipients. Am. J. Transplant.7(4), 941–948 (2007).
   PubMed Web of Science ®Google Scholar
• Gutierrez-Dalmau A, Campistol JM. Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review. Drugs67(8), 1167–1198 (2007).
   PubMed Web of Science ®Google Scholar
• Dantal J, Pohanka E. Malignancies in renal transplantation: an unmet medical need. Nephrol. Dial. Transplant.22(Suppl. 1), i4–i10 (2007).
   PubMedGoogle Scholar
• Vajdic CM, McDonald SP, McCredie MR. Cancer incidence before and after kidney transplantation. JAMA296(23), 2823–2831 (2006).
   PubMed Web of Science ®Google Scholar
• Buell JF, Papaconstantinou HT, Skalow B et al. De novo colorectal cancer: five year survival is markedly lower in transplant recipients compared with the general population. Transplant Proc.37(2), 960–961 (2005).
   Google Scholar
• Andrés A. Cancer incidence after immunosuppressive treatment following kidney transplantation. Crit. Rev. Oncol. Hematol.56(1), 71–85 (2005).
   PubMed Web of Science ®Google Scholar
• Maisonneuve P, Agodoa L, Gellert R. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet354(9173), 93–99 (1999).
   PubMed Web of Science ®Google Scholar
• Buccianti G, Maisonneuve P, Ravasi B et al. Cancer among patients on renal replacement therapy: a population-based survey in Lombardy, Italy. Int. J. Cancer66(5), 591–593 (1996).
   Google Scholar
• Vamvakas S, Bahner U, Heidland A. Cancer in end-stage renal disease: potential factors involved. Am. J. Nephrol.18(2), 89–95 (1998).
   PubMedGoogle Scholar
• Lee S, Wasserberg N, Petrone P et al. The prevalence of colorectal neoplasia in patients with end-stage renal disease: a case-control study. Int. J. Colorectal Dis.3(1), 47–51 (2008).
   Google Scholar
• Stewart T, Henderson R, Grayson H, Opelz G. Reduced incidence of rectal cancer, compared to gastric and colonic cancer, in a population of 73,076 men and women chronically immunosuppressed. Clin. Cancer Res.3(1), 51–55 (1997).
   PubMed Web of Science ®Google Scholar
• Webster AC, Craig JC, Simpson JM, Jones MP, Chapman JR. Identifying high risk groups and quantifying absolute risk of cancer after kidney transplantation: a cohort of 15 183 recipients. Am. J. Transplant.7, 2140–2151 (2007).
   PubMed Web of Science ®Google Scholar
• Kasiske BL, Snyder JJ, Gilbertson DT, Wang C. Cancer after kidney transplantation in the United States. Am. J. Transplant.4(6), 905–913 (2004).
   PubMed Web of Science ®Google Scholar
• Saidi RF, Dudrick PS, Goldman MH. Colorectal cancer after renal transplantation. Transplant Proc.35(4), 1410–1420 (2003).
   PubMed Web of Science ®Google Scholar
• Johnson EE, Leverson GE, Pirsch JD, Heise CP. A 30-year analysis of colorectal adenocarcinoma in transplant recipients and proposal for altered screening. J. Gastrointest. Surg.11(3), 272–279 (2007).
   PubMed Web of Science ®Google Scholar
• Wimmer CD, Rentsch M, Crispin A, Illner WD. The janus face of immunosuppression – de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich. Kidney Int.71(12), 1271–1280 (2007).
   PubMed Web of Science ®Google Scholar
• Kehinde EO, Petermann A, Morgan JD. Triple therapy and incidence of de novo cancer in renal transplant recipients. Br. J. Surg.81(7), 985–986 (1994).
   PubMedGoogle Scholar
• Penn I. Tumors after renal and cardiac transplantation. Hematol. Oncol. Clin. North Am.7(2), 431–445 (1993).
   PubMed Web of Science ®Google Scholar
• Vilardell J, Oppenheimer F, Castelao AM et al. Cancer after transplantation in Catalonia. Transplant Proc.24(1), 124 (1992).
   PubMed Web of Science ®Google Scholar
• Blohmé I, Brynger H. Malignant disease in renal transplant patients. Transplantation39(1), 23–25 (1985).
   PubMed Web of Science ®Google Scholar
• Birkeland SA. Malignant tumors in renal transplant patients. The Scandia transplant material. Cancer51(9), 1571–1575 (1983).
   Google Scholar
• Grulich A, Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/ADIS compared with immunosuppressed transplant recipients: a meta analysis. Lancet370, 59–67 (2007).
   PubMed Web of Science ®Google Scholar
• Ebisui C, Okazaki M, Kanai T et al. Clinicopathological study of colorectal cancers after renal transplantation. Transplant Proc.32(7), 1984–1985 (2000).
   Google Scholar
• Wong G, Chapman JR, Craig JC. Cancer screening in renal transplant recipients: what is the evidence? Clin. J. Am. Soc. Nephrol.3(Suppl. 2) s87–s100 (2008).
   Google Scholar
• Kasiske BL, Cangro CB, Hariharan S et al. The evaluation of renal transplantation candidates: clinical practice guidelines. Am. J. Transplant.1(Suppl. 2), 3–95 (2001).
   PubMedGoogle Scholar
• Parikshak M, Pawlak SE, Eggenberger JC. The role of endoscopic colon surveillance in the transplant population. Dis. Colon Rectum.45(12), 1655–1660 (2002).
   Google Scholar
• Papaconstantinou HT, Sklow B, Hanaway MJ et al. Characteristics and survival patterns of solid organ transplant patients developing de novo colon and rectal cancer. Dis. Colon Rectum.47(11), 1898–1903 (2004).
   Google Scholar
• Wong G, Howard K, Craig, J, Chapman J. Cost-effectiveness of colorectal cancer screening in renal transplant recipients. Transplantation85(4), 532–541 (2008).
   Google Scholar
• Ajithkumar TV, Parkinson CA, Butler A, Hatcher HM. Management of solid tumours in organ-transplant recipients. Lancet Oncol.8(10), 921–932 (2007).
   PubMed Web of Science ®Google Scholar